Search - tctmd.com

Displaying 181 - 200 of 1123

Sort: Relevancy | Date

Presentation TCT 2019

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Presenter: Azfar Zaman

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Presenter: Ehrin Armstrong

September 25, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

Podcast TCTMD Talking Points

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

July 17, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 29, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation OPCI 2019

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

Presenter: Gary S. Mintz

March 09, 2019

Presentation JIM 2019

Magmaris, a Resorbable Magnesium Scaffold here to stay

Presenter: Johan Bennett

February 15, 2019

News Daily News

No Excuses: Routine, High-Volume Exercise in Men Not Associated With Increased Mortality

Michael O'Riordan

February 01, 2019

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Todd Neale

November 12, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

Advertisement

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

What I Am Most Looking Forward to at TCT 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

Magmaris, a Resorbable Magnesium Scaffold here to stay

No Excuses: Routine, High-Volume Exercise in Men Not Associated With Increased Mortality

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Top News in Coronary Artery Disease: 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

Off Script: Phantom Hearts and the Elusive Nature of Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content